Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study
| Image |  |
|---|---|
| Description | article |
| Author/s |
author: Claudia Maggi Maria Di Bartolomeo Katia F. Dotti Federica Perrone Roberto Iacovelli Filippo Pietrantonio |
| Publication date | January 27, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |